Biotech startups in Guangzhou, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Zhiyi Pharmaceutics | Guangzhou | Series C | $13.8M | 2024-03-28 |
| Canton Biologics | Guangzhou | Series C | $41.3M | 2023-09-13 |
2 rows of the CSV in 5 of its 18 columns.
- The 52 biotech startups in Guangzhou, China have raised $661.8M in total.
- 8 of them closed their most recent round in the last 12 months, $191.5M combined.
- The largest of those rounds is Syneron's $150.0M Series B, dated March 2026.
- The most recent is Libo Biotech's $15.0M Series A on 30 October 2026.
- SDIC Venture Capital is an investor in 2 of them, more than any other fund.
- Health care is the most common other sector, with 45 companies (87%).
- 24% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 51 to 100 employees (34% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
2 of 52| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Zhiyi Pharmaceutics | Zhiyi Pharmaceutics researches and develops second-generation probiotics and live biotherapeutics. | Biotech | Series C | $13.8M | 2024-03-28 | Shenzhen Capital Group, SDIC Venture Capital, Sinoking Capital | 51 to 100 | 2013 | |
| Canton Biologics | Canton Biologics provides biologics contract development and manufacturing outsourcing services. | Biotech | Series C | $41.3M | 2023-09-13 | $41.7M | SDIC Venture Capital, Rongtuo Capital Management, Taipu Life Sciences Investment | 101 to 250 | 2016 |
Table 1. Biotech startups in Guangzhou, China: the 2 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 52.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | SDIC Venture Capital | Venture capital firm | Xicheng, China | 2 | 4% | ||
| 2 | Sinoking Capital | Venture capital firm | Beijing, China | 1 | 2% | ||
| 3 | Shenzhen Capital Group | Venture capital firm | Nanshan, China | 1 | 2% | ||
| 4 | Guangzhou Finance Holdings | Private equity firm | Guangzhou, China | 1 | 2% | 1 | MingCeler |
| 5 | Taipu Life Sciences Investment | 1 | 2% | ||||
| 6 | Rongtuo Capital Management | Venture capital firm | Wujiang, China | 1 | 2% | ||
| 7 | Yael Capital Management Limited | Venture capital firm | Shenzhen, China | 1 | 2% | ||
| 8 | Yinxinggu Capital | Venture capital firm | Hangzhou, China | 1 | 2% | ||
| 9 | Xiaochi Capital | Venture capital firm | Hangzhou, China | 1 | 2% | ||
| 10 | Tiantu Capital | Venture capital firm | Shenzhen, China | 1 | 2% | ||
| 11 | Wanlian Tianze | Venture capital firm | Guangzhou, China | 1 | 2% | 1 | Huateng Biotech |
| 12 | Guangzhou Science City Venture Capital | Private equity firm | Huangpu, China | 1 | 2% | ||
| 13 | Knowledge City Venture Capital | Corporate venture arm | Guangzhou, China | 1 | 2% | ||
| 14 | K2VC | Angel group | Beijing, China | 1 | 2% | ||
| 15 | Linear Capital | Venture capital firm | Shanghai, China | 1 | 2% |
Table 2. Biotech startups in Guangzhou, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 45 | 87% | $368.6M |
| Artificial intelligence | 1 | 2% | $250.0M |
| Software | 1 | 2% | $250.0M |
| Hardware | 1 | 2% | $14.1M |
| Energy | 1 | 2% |
Table 3. Biotech startups in Guangzhou, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Seed | 13 | 25% | $477K |
| Series A | 14 | 27% | $14.6M |
| Series B | 11 | 21% | $10.5M |
| Series C | 12 | 23% | $14.5M |
| Series D+ | 2 | 4% | $87.0M |
Table 4. Biotech startups in Guangzhou, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 2 | 25% | $25.5M |
| August 2026 | 1 | 12% | $1.5M |
| July 2026 | 1 | 12% | |
| March 2026 | 2 | 25% | $164.5M |
| January 2026 | 1 | 12% | |
| November 2025 | 1 | 12% |
Table 5. Biotech startups in Guangzhou, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 7 | 13% | $191.5M |
| 2025 | 6 | 12% | $13.9M |
| 2024 | 4 | 8% | $69.2M |
| 2023 | 9 | 17% | $69.3M |
| 2022 | 8 | 15% | $231.8M |
| 2021 | 3 | 6% | $127.0M |
Table 6. Biotech startups in Guangzhou, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 3 | 6% |
| 2020 to 2022 | 9 | 18% |
| 2015 to 2019 | 23 | 45% |
| 2010 to 2014 | 8 | 16% |
| Before 2010 | 8 | 16% |
Table 7. Biotech startups in Guangzhou, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 4 | 11% |
| 11 to 50 | 9 | 26% |
| 51 to 100 | 12 | 34% |
| 101 to 250 | 6 | 17% |
| 251 to 500 | 3 | 9% |
| 501 to 1,000 | 1 | 3% |
Table 8. Biotech startups in Guangzhou, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Guangzhou, China. On 16 November 2026 that is 52 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 2 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 52 rows: 21 have no round amount, 0 no city and 18 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Guangzhou, China are on the list?
- 52, in the file dated 16 November 2026. 8 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 52 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 2 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.